Clinical Trial Update: Safety and Efficacy Study of NGGT003 in Hemophilia A Patients [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial is evaluating the safety and efficacy of NGGT003 in patients with Hemophilia A. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• NGGT003

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Hemophilia A | EARLY_Phase 1 | Status: RECRUITING